Literature DB >> 3532006

Kawasaki syndrome.

R V Hicks, M E Melish.   

Abstract

Kawasaki's syndrome is an acute, largely self-limited multisystem vasculitis of childhood with prominent rheumatic complaints, involving both the heart and the joints. Although the etiologic agent has not been discovered, the evidence appears overwhelming that a microbial agent is the responsible trigger for this multisystem disease. Immunologically mediated phenomena appear to be important in the development of the significant complications of KS carditis, coronary vasculitis, and arthritis. Although truly effective therapy is not yet available, there is an exciting possibility that immunologic treatment may have beneficial effect. More effective preventive and therapeutic methods will become available when the elusive agent is discovered.

Entities:  

Mesh:

Year:  1986        PMID: 3532006     DOI: 10.1016/s0031-3955(16)36113-2

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  14 in total

1.  Association of Kawasaki disease and interstitial nephritis.

Authors:  P A Veiga; D Pieroni; W Baier; L G Feld
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

2.  Thrombocytopenia: a complication of Kawasaki disease.

Authors:  T Hara; Y Mizuno; H Akeda; J Fukushige; K Ueda; T Aoki; H Sunagawa; S Honda; T Hijii; Y Yamaguchi
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

3.  Neutropenia in Kawasaki disease.

Authors:  T Hara; Y Mizuno; K Ueda; H Akeda; T Aoki; S Honda; Y Yamaguchi; T Hosoyamada
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

4.  Kawasaki disease presenting as focal colitis.

Authors:  C J Chung; S Rayder; W Meyers; J Long
Journal:  Pediatr Radiol       Date:  1996-07

Review 5.  Vasculitis in childhood.

Authors:  I Roberti; L Reisman; J Churg
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

6.  Pseudohyperkalaemia in Kawasaki disease.

Authors:  T Shimizu; Y Yamashiro; K Yabuta
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

7.  Salicylate treatment in Kawasaki disease: high dose or low dose?

Authors:  T Akagi; H Kato; O Inoue; N Sato
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

8.  Cardiovascular manifestations in Kawasaki disease.

Authors:  S Cullen; D F Duff; B Denham; O C Ward
Journal:  Ir J Med Sci       Date:  1989-10       Impact factor: 1.568

9.  Associated symptoms in the ten days before diagnosis of Kawasaki disease.

Authors:  Annette L Baker; Minmin Lu; L LuAnn Minich; Andrew M Atz; Gloria L Klein; Rosalind Korsin; Linda Lambert; Jennifer S Li; Wilbert Mason; Elizabeth Radojewski; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2008-11-28       Impact factor: 4.406

10.  Carbamazepine hypersensitivity and rickettsiosis mimicking Kawasaki disease.

Authors:  S Parha; A Garoufi; P Yiallouros; C Theodoridis; T Karpathios
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.